21 May 2013
Keywords: Ipsen, GuidAge study, EGb 761, Alzhiemer's
Article | 23 June 2010
French drugmaker Ipsen has released top-line results of GuidAge, the longest (five years) and largest (2,854 subjects) European study in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2010
20 May 2013
© 2013 thepharmaletter.com